Related Experiment Video

Updated: Jan 24, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

20.5K

[Analysis of polysomnography results between pre- and post-operation in pediatric obstructive sleep apnea hypopnea

G P Yin1, J Y Ye1, J K Xu1

  • 1Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery
|May 29, 2019
PubMed

Insights

Adenotonsillectomy significantly improves pediatric obstructive sleep apnea hypopnea syndrome (OSAHS) by reducing respiratory events and enhancing sleep architecture. However, some children may not achieve complete relief from this surgical intervention.

Area of Science:

  • Otolaryngology
  • Pediatric Sleep Medicine
  • Respiratory Medicine

Background:

  • Pediatric obstructive sleep apnea hypopnea syndrome (OSAHS) significantly impacts children's health and development.
  • Adenotonsillectomy is a common treatment, but objective data on its effectiveness are crucial.

Purpose of the Study:

  • To objectively evaluate the effects of adenotonsillectomy on pediatric OSAHS using polysomnography (PSG).
  • To analyze changes in respiratory events and sleep architecture post-surgery.

Main Methods:

  • 56 pediatric OSAHS patients underwent pre- and post-operative PSG analysis.
  • Comparison of respiratory parameters and sleep architecture using statistical tests (paired t-test, unpaired t-test, rank sum test).

Main Results:

  • Adenotonsillectomy demonstrated an 85.71% short-term cure rate for pediatric OSAHS.
  • Significant decreases were observed in apnea-hypopnea index (AHI), oxygen desaturation index (ODI), and arousal index.
  • Improvements in sleep architecture included increased stage II and REM sleep percentages.

Conclusions:

  • Pediatric OSAHS exhibits distinct respiratory event characteristics compared to adults.
  • Adenotonsillectomy effectively reduces respiratory events and improves sleep architecture in most pediatric OSAHS patients.
  • Complete resolution of OSAHS is not achieved in all patients following adenotonsillectomy.

Keywords:
AdenotonsillectomyChildrenPolysomnographySleep apnea, obstructive

More Related Videos

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.2K
Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments08:36

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments

Published on: August 8, 2019

12.7K

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
514
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
307
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
200
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
261